BIOLINERX     Print Page  Close Window

Investor relations home

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology and immunology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

BioLineRx's leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refrac... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
03/19/18
BIO Asia
03/20/18
Oppenheimer
06/01/18
through
06/05/18
ASCO Annual Meeting
What's new
DateTitle
02/13/18
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types